ASBP
Aspire Biopharma Holdings Inc. (ASBP)
NASDAQ · Healthcare
Aspire Biopharma Holdings Inc. annual/quarterly shareholder equity history from 2025 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Aspire Biopharma Holdings Inc. shareholder equity for the quarter ending December 31, 2025 were -6.4M.
- Aspire Biopharma Holdings Inc. shareholder equity for 2025 were -6.4M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Aspire Biopharma Holdings Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-6 |
| Aspire Biopharma Holdings Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $-6 |
Aspire Biopharma Holdings Inc. Shareholder Equity — FAQ
Aspire Biopharma Holdings Inc. (ASBP) shareholder equity over the last 1 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ASBP's shareholder equity history?
The chart and table above show Aspire Biopharma Holdings Inc.'s shareholder equity by year and by quarter, including the growth rate.